|
市場調査レポート
商品コード
1448642
子宮頸がん診断の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測Global Cervical Cancer Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
||||||
カスタマイズ可能
|
|||||||
| 子宮頸がん診断の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測 |
|
出版日: 2024年02月01日
発行: Value Market Research
ページ情報: 英文 253 Pages
納期: 即日から翌営業日
|
- 全表示
- 概要
- 図表
- 目次
子宮頸がん診断市場の世界需要は、2023年の59億4,000万米ドルから2032年には101億4,000万米ドル近くの市場規模に達すると推定され、調査期間2024～2032年のCAGRは6.12%です。
子宮頸がん診断には、一般的にパップスメアやHPV検査などのスクリーニング検査による子宮頸部の異常の同定と評価が含まれます。これらの診断は早期発見において重要な役割を果たし、子宮頸がんを予防または治療するためのタイムリーな医療介入を可能にします。コルポスコピーや分子検査などの先進技術は診断精度を高め、女性の健康状態の改善に貢献しています。
市場力学
子宮頸がん診断市場は、子宮頸がん検診に対する意識の高まり、世界の子宮頸がん罹患率の上昇、診断方法の技術的進歩などの要因によって推進されています。定期的な検診と早期発見を推進する医療機関や政府によるイニシアチブの高まりが市場拡大に寄与しています。分子診断、HPV検査、液体細胞診技術の採用は、子宮頸がん診断の精度と効率を高める。さらに、女性の健康に焦点を当てた教育キャンペーンが、予防医療対策を奨励しています。診断プロセスにおけるAIと自動化の統合は、手順をさらに合理化し、子宮頸がん診断市場の成長を促進します。
調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、子宮頸がん診断の世界市場における各セグメントを包括的に評価することもできます。子宮頸がん診断産業の成長と動向は、本調査に全体的なアプローチを提供します。
市場セグメンテーション
子宮頸がん診断市場レポートの本セクションでは、国別と地域別のセグメントに関する詳細なデータを提供し、それによって戦略家がそれぞれの製品またはサービスの対象層を特定し、今後のビジネスチャンスに役立てることができます。
タイプ別
- PAP検査
- HPV検査
- コルポスコピー
- 子宮頸部生検
- 膀胱鏡検査
年齢層別
- 20～40歳
- 40歳以上
用途別
- 病院
- 研究所
- 診断センター
地域分析
このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける子宮頸がん診断市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、本レポートは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。
ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。
目次
第1章 序文
第2章 エグゼクティブサマリー
- 市場のハイライト
- 世界市場スナップショット
第3章 子宮頸がん診断-産業分析
- イントロダクション-市場力学
- 市場促進要因
- 市場抑制要因
- 市場機会
- 業界動向
- ポーターのファイブフォース分析
- 市場魅力度分析
第4章 バリューチェーン分析
- バリューチェーン分析
- 原材料分析
- 原材料リスト
- 原材料メーカーリスト
- 主要原材料の価格動向
- 潜在的バイヤーのリスト
- マーケティングチャネル
- 直接マーケティング
- 間接マーケティング
- マーケティングチャネル発展動向
第5章 子宮頸がん診断の世界市場分析：タイプ別
- タイプ別概要
- 実績データと予測データ
- タイプ別分析
- PAP検査
- HPV検査
- コルポスコピー
- 子宮頸部生検
- 膀胱鏡検査
第6章 子宮頸がん診断の世界市場分析：年齢層別
- 年齢層別概要
- 実績データと予測データ
- 年齢層別分析
- 20～40歳
- 40歳以上
第7章 子宮頸がん診断の世界市場分析：最終用途別
- 最終用途別概要
- 実績データと予測データ
- 最終用途別分析
- 病院
- 研究所
- 診断センター
第8章 子宮頸がん診断の世界市場分析：地域別
- 地域別展望
- イントロダクション
- 北米売上分析
- 概要、実績と予測
- 北米：セグメント別
- 北米：国別
- 米国
- カナダ
- メキシコ
- 欧州売上分析
- 概要、実績と予測
- 欧州：セグメント別
- 欧州：国別
- 英国
- フランス
- ドイツ
- イタリア
- ロシア
- その他の欧州
- アジア太平洋売上分析
- 概要、実績と予測
- アジア太平洋：セグメント別
- アジア太平洋：国別
- 中国
- インド
- 日本
- 韓国
- オーストラリア
- 東南アジア
- その他のアジア太平洋
- ラテンアメリカ売上分析
- 概要、実績と予測
- ラテンアメリカ：セグメント別
- ラテンアメリカ：国別
- ブラジル
- アルゼンチン
- ペルー
- チリ
- その他のラテンアメリカ
- 中東・アフリカ売上分析
- 概要、実績と予測
- 中東・アフリカ：セグメント別
- 中東・アフリカ：国別
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他の中東・アフリカ
第9章 子宮頸がん診断企業の競合情勢
- 子宮頸がん診断市場競争
- パートナーシップ/提携/合意
- 合併・買収
- 新製品の上市
- その他の開発
第10章 企業プロファイル
- 企業シェア分析
- 市場集中度
- Abbott Laboratories
- Quigan NV
- Thermo Fisher Scientific Inc.
- Carl Zeiss AG
- Dickinson and Company
- Hologic Inc.
- CooperSurgical Inc.
- Siemens Healthineers
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- Analysis by Type (USD MN)
- PAP Testing Market Sales by Geography (USD MN)
- HPV Testing Market Sales by Geography (USD MN)
- Colposcopy Market Sales by Geography (USD MN)
- Cervical Biopsies Market Sales by Geography (USD MN)
- Cystoscopy Market Sales by Geography (USD MN)
- Analysis Market by Age Group (USD MN)
- 20-40 Years Market Sales by Geography (USD MN)
- Above 40 Years Market Sales by Geography (USD MN)
- Analysis by End Use (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Laboratories Market Sales by Geography (USD MN)
- Diagnostic Centers Market Sales by Geography (USD MN)
- Global Cervical Cancer Diagnostics Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Cervical Cancer Diagnostics Report
- Market Research Process
- Market Research Methodology
- Global Cervical Cancer Diagnostics Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Type
- Market Attractiveness Analysis by Age Group
- Market Attractiveness Analysis by End Use
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Type (USD MN)
- PAP Testing Market Sales by Geography (USD MN)
- HPV Testing Market Sales by Geography (USD MN)
- Colposcopy Market Sales by Geography (USD MN)
- Cervical Biopsies Market Sales by Geography (USD MN)
- Cystoscopy Market Sales by Geography (USD MN)
- Global Market Analysis by Age Group (USD MN)
- 20-40 Years Market Sales by Geography (USD MN)
- Above 40 Years Market Sales by Geography (USD MN)
- Global Market Analysis by End Use (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Laboratories Market Sales by Geography (USD MN)
- Diagnostic Centers Market Sales by Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
The global demand for Cervical Cancer Diagnostics Market is presumed to reach the market size of nearly USD 10.14 Billion by 2032 from USD 5.94 Billion in 2023 with a CAGR of 6.12% under the study period 2024 - 2032.
Cervical cancer diagnostics involve the identification and assessment of abnormalities in the cervix, typically through screening tests like Pap smears and HPV testing. These diagnostics play a crucial role in early detection, allowing for timely medical intervention to prevent or treat cervical cancer. Advanced technologies, such as colposcopy and molecular testing, enhance diagnostic accuracy, contributing to improved women's health outcomes.
MARKET DYNAMICS
The cervical cancer diagnostics market is propelled by factors such as increasing awareness of cervical cancer screening, rising incidences of cervical cancer globally, and technological advancements in diagnostic methods. Growing initiatives by healthcare organizations and governments to promote regular screenings and early detection contribute to market expansion. The adoption of molecular diagnostics, HPV testing, and liquid-based cytology techniques enhances the accuracy and efficiency of cervical cancer diagnosis. Additionally, a focus on women's health, coupled with educational campaigns, encourages preventive healthcare measures. The integration of AI and automation in diagnostic processes further streamlines procedures, fostering growth in the cervical cancer diagnostics market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cervical cancer diagnostics. The growth and trends of cervical cancer diagnostics industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the cervical cancer diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- PAP Testing
- HPV Testing
- Colposcopy
- Cervical Biopsies
- Cystoscopy
By Age Group
- 20-40 Years
- Above 40 Years
By End Use
- Hospitals
- Laboratories
- Diagnostic Centers
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Cervical Cancer Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cervical Cancer Diagnostics market include Abbott Laboratories, Quigan NV, Thermo Fisher Scientific Inc, Carl Zeiss AG, Dickinson and Company, Hologic Inc, CooperSurgical Inc, Siemens Healthineers. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . CERVICAL CANCER DIAGNOSTICS - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Age Group
- 3.7.3 Market Attractiveness Analysis By End Use
- 3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET ANALYSIS BY TYPE
- 5.1 Overview by Type
- 5.2 Historical and Forecast Data
- 5.3 Analysis by Type
- 5.4 PAP Testing Historic and Forecast Sales by Regions
- 5.5 HPV Testing Historic and Forecast Sales by Regions
- 5.6 Colposcopy Historic and Forecast Sales by Regions
- 5.7 Cervical Biopsies Historic and Forecast Sales by Regions
- 5.8 Cystoscopy Historic and Forecast Sales by Regions
6 . GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET ANALYSIS BY AGE GROUP
- 6.1 Overview by Age Group
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Age Group
- 6.4 20-40 Years Historic and Forecast Sales by Regions
- 6.5 Above 40 Years Historic and Forecast Sales by Regions
7 . GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET ANALYSIS BY END USE
- 7.1 Overview by End Use
- 7.2 Historical and Forecast Data
- 7.3 Analysis by End Use
- 7.4 Hospitals Historic and Forecast Sales by Regions
- 7.5 Laboratories Historic and Forecast Sales by Regions
- 7.6 Diagnostic Centers Historic and Forecast Sales by Regions
8 . GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE CERVICAL CANCER DIAGNOSTICS COMPANIES
- 9.1. Cervical Cancer Diagnostics Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10 . COMPANY PROFILES OF CERVICAL CANCER DIAGNOSTICS INDUSTRY
- 10.1. Company Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Abbott Laboratories
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
- 10.4. Quigan NV
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
- 10.5. Thermo Fisher Scientific Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
- 10.6. Carl Zeiss AG
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
- 10.7. Dickinson and Company
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
- 10.8. Hologic Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
- 10.9. CooperSurgical Inc.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
- 10.10. Siemens Healthineers
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
